Back to Search
BIPIN JOSHI, MD
MD
Specialist
NPI: 1336162486IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
A44090(CA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 1979
Research & Publications (20)
Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
PMID 18922892·Cancer Res·2008
8-other
Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.
PMID 19010904·Cancer Res·2008
7-preclinical
Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.
PMID 16918502·Biochem J·2007
8-other
Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors.
PMID 15735762·Oncogene·2005
8-other
A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis.
PMID 14637159·Biochem Biophys Res Commun·2003
8-other
Antidiabetic Indian plants: a good source of potent amylase inhibitors.
PMID 18955350·Evid Based Complement Alternat Med·2011
8-other
Antidiabetic Properties of Azardiracta indica and Bougainvillea spectabilis: In Vivo Studies in Murine Diabetes Model.
PMID 19389871·Evid Based Complement Alternat Med·2011
8-other
Melatonin-induced changes in ovarian function in the freshwater fish Channa punctatus (Bloch) held in long days and continuous light.
PMID 19501093·Gen Comp Endocrinol·2010
7-preclinical
Epidemiological and clinicotherapeutic study of leucoderma in dairy cattle and buffaloes.
PMID 19448259·Vet Rec·2009
7-preclinical
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials.
PMID 19113955·J Med Chem·2009
7-preclinical
Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.
PMID 19491224·J Clin Endocrinol Metab·2009
7-preclinical
Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography.
PMID 19181263·Nucl Med Biol·2009
7-preclinical
Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.
PMID 19502066·Bioorg Med Chem·2009
7-preclinical
Developmental emergence of power-law wake behavior depends upon the functional integrity of the locus coeruleus.
PMID 19639755·Sleep·2009
7-preclinical
Ratiometric and turn-on monitoring for heavy and transition metal ions in aqueous solution with a fluorescent peptide sensor.
PMID 19269448·Talanta·2009
8-other
On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.
PMID 19446568·J Theor Biol·2009
8-other
Structure and activities of a steroidal saponin from Chlorophytum nimonii (Grah) Dalz.
PMID 19521911·Nat Prod Res·2009
7-preclinical
Indolicidin-derived antimicrobial peptide analogs with greater bacterial selectivity and requirements for antibacterial and hemolytic activities.
PMID 19038369·Biochim Biophys Acta·2009
8-other
Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.
PMID 19419868·Bioorg Med Chem Lett·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7215 N FRESNO ST STE 103
FRESNO, CA 93720 - Phone
- (559) 438-1111
Quick Facts
- NPI
- 1336162486
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile